Analyst Ratings

Date	Action	Analyst	Rating	Target
May-08-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Feb-27-25	Reiterated	Barclays	Overweight	$4.00
Feb-26-25	Downgrade	HC Wainwright & Co.	Buy → Neutral
Nov-05-24	Reiterated	H.C. Wainwright	Buy	$8.00
Oct-22-24	Reiterated	B.Riley Financial		$5.50
Sep-09-24	Initiated	Leerink	Outperform	$7.00
Jun-10-24	Reiterated	Goldman Sachs	Buy	$5.00 → $6.00
Jun-10-24	Reiterated	Stifel Nicolaus	Hold	$6.00 → $7.00
Apr-30-24	Reiterated	Robert W. Baird		$4.50
Apr-30-24	Downgrade	Baird	Outperform → Neutral

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023
Total Revenue	196	184	77	Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A	26	5	1
Gross Profit	170	179	76
Selling, General and Administrative Excl. Other	155	159	146
Research and Development	74	74	104
Other Operating Expense	-23	0	-1
Operating Income	-37	-54	-174
Interest Expense	32	33	19
Unusual Expense	—	—	—
Non-Operating Income (Expense)	0	-1	-18
Net Income Before Taxes	-69	-86	-175
Income Taxes	0	0	0
Consolidated Net Income	-69	-86	-175
Net Income From Continuing Operations	-69	-86	-175
Net Income	-69	-86	-175
EPS (Recurring)	-0.10	-0.13	-0.27
EPS (Basic, Before Extraordinaries)	-0.10	-0.13	-0.27
EPS (Diluted)	-0.10	-0.13	-0.27
EBITDA	-38	-52	-155
Other After Tax Adjustments	—	—	—
Stock Option Compensation Expense	—	—	—
Price To Earnings Ratio	—	—	—
Price To Sales Ratio	4.30	4.79	—
Gross Margin	86.73	97.28	98.70
Operating Margin	-18.88	-29.35	-225.97
Net Margin	-35.20	-46.74	-227.27
Shares Outstanding	669	667	646
Market Capitalization	843	880	—
Operating Lease Expense	—	—	—

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBERTSON MICHELLE	EVP, CHIEF FINANCIAL OFFICER	Feb 18 '26	Option Exercise	0.00	55,000	0	82,500	Feb 19 12:00 AM
ROBERTSON MICHELLE	EVP, CHIEF FINANCIAL OFFICER	Feb 18 '26	Sale	1.94	9,855	19,119	17,645	Feb 19 12:00 AM
LAWLIS V BRYAN	Director	May 09 '25	Buy	1.18	13,300	15,667	13,300	May 13 12:00 AM
Samuels Scott Alan	EVP, Chief Legal Officer	Feb 27 '25	Buy	1.61	15,000	24,150	26,682	Mar 03 12:00 AM
Ziegler James	EVP, Chief Commercial Officer	Feb 27 '25	Buy	1.60	100,000	160,000	100,000	Mar 03 12:00 AM
SCARLETT JOHN A	Chairman, President and CEO	Feb 27 '25	Buy	1.76	12,500	22,063	12,500	Mar 03 12:00 AM
GRETHLEIN ANDREW J	EVP, Chief Operating Officer	Jul 08 '24	Sale	4.56	674,348	3,073,004	0	Jul 10 12:00 AM
GRETHLEIN ANDREW J	EVP, Chief Operating Officer	Jul 08 '24	Option Exercise	1.72	1,127,152	1,938,702	674,348	Jul 10 12:00 AM
Feller Faye	EVP, Chief Medical Officer	Jun 10 '24	Option Exercise	1.19	575,800	683,386	155,400	Jun 12 12:00 AM
Feller Faye	EVP, Chief Medical Officer	Jun 10 '24	Sale	4.63	287,900	1,334,129	0	Jun 12 12:00 AM
Kapur Anil	EVP, Corp Strategy & CCO	Jun 10 '24	Option Exercise	1.06	843,750	894,376	421,875	Jun 12 12:00 AM
Kapur Anil	EVP, Corp Strategy & CCO	Jun 10 '24	Sale	4.64	421,875	1,959,609	0	Jun 12 12:00 AM
SCARLETT JOHN A	Chairman, President and CEO	Jun 04 '24	Sale	4.00	600,000	2,400,000	600,000	Jun 05 12:00 AM
SCARLETT JOHN A	Chairman, President and CEO	Jun 04 '24	Option Exercise	2.54	1,200,000	3,048,000	600,000	Jun 05 12:00 AM
LAWLIS V BRYAN	Director	May 15 '24	Option Exercise	1.94	70,000	135,800	35,000	May 17 12:00 AM


Market Cap	789.07M	Forward P/E	19.38	EPS next Y	0.07	Insider Trans	0.01%	Shs Float	-	Perf Month	3.28%


Enterprise Value	970.13M	PEG	-	EPS next Q	-0.01	Inst Own	-	Short Float	-	Perf Quarter	-18.71%


Income	-66676482.00	P/S	4.02	EPS this Y	76.67%	Inst Trans	-	Short Ratio	-	Perf Half Y	-5.97%


Sales	196.12M	P/B	3.59	EPS next Y	378.58%	ROA	-13.03%	Short Interest	-	Perf YTD	-4.55%


Book/sh	0.36	P/C	-	EPS next 5Y	-	ROE	-28.90%	52W High	2.01 -37.31%	Perf Year	-13.10%


Cash/sh	0.49	P/FCF	-	EPS past 3/5Y	-	ROIC	-7.77%	52W Low	1.04 21.15%	Perf 3Y	-


Dividend Est.	-	EV/EBITDA	-26.26	Sales past 3/5Y	468.77% -	Gross Margin	86.59%	Volatility	4.17% 3.62%	Perf 5Y	-


Dividend TTM	-	EV/Sales	4.95	EPS Y/Y TTM	66.67%	Oper. Margin	-19.05%	ATR (14)	0.07	Perf 10Y	-


Dividend Ex-Date	-	Quick Ratio	6.78	Sales Y/Y TTM	154.55%	Profit Margin	-35.48%	RSI (14)	51.51	Recom	2.23


Dividend Gr. 3/5Y	-	Current Ratio	6.78	EPS Q/Q	-	SMA20	5.18%	Beta	1.68	Target Price	5.89


Payout	0.00%	Debt/Eq	1.10	Sales Q/Q	30.00%	SMA50	-9.33%	Rel Volume	1.49	Prev Close	1.23


Employees	229	LT Debt/Eq	1.03	Earnings	Aug 05	SMA200	-9.18%	Avg Volume	14.52M	Price	1.26


IPO Date	Jul 31, 1996	Option/Short	No / Yes	EPS/Sales Surpr.	66.67% 1.96%	Net Debt/EBITDA	-4.90	Volume	21,645,471	Change	2.44%

GERN